E. Fıdan Et Al. , "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.," Acta diabetologica , vol.48, pp.297-302, 2011
Fıdan, E. Et Al. 2011. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.. Acta diabetologica , vol.48 , 297-302.
Fıdan, E., Onder, E., Yılmaz, M., Yilmaz, H., Kocak, M., Karahan, C., ... Erem, C.(2011). The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.. Acta diabetologica , vol.48, 297-302.
Fıdan, E Et Al. "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.," Acta diabetologica , vol.48, 297-302, 2011
Fıdan, E Et Al. "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.." Acta diabetologica , vol.48, pp.297-302, 2011
Fıdan, E. Et Al. (2011) . "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.." Acta diabetologica , vol.48, pp.297-302.
@article{article, author={E Fıdan Et Al. }, title={The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.}, journal={Acta diabetologica}, year=2011, pages={297-302} }